Baxter International Inc. opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Baxter International Inc.

Patent Number:
Title:
Compacted Hemostatic Cellulosic Aggregates
Applicant:
Opposition Date:
Mar 7, 2024
Patent Number:
Title:
Oxidized Regenerated Cellulose Hemostatic Powders And Methods Of Making
Applicant:
Opposition Date:
Oct 19, 2022
Patent Number:
Title:
Oxidized Regenerated Cellulose Hemostatic Powders And Methods Of Making
Applicant:
Opposition Date:
Jul 31, 2019
Patent Number:
Title:
Hemostatic Pad Assembly Kit And Method
Applicant:
Opposition Date:
Jul 4, 2018
Patent Number:
Title:
Procoagulant Peptides And Their Derivatives And Uses Therefor
Applicant:
Opposition Date:
Jun 13, 2018
Patent Number:
Title:
A Resorbable Laparoscopically Deployable Hemostat
Applicant:
Opposition Date:
May 30, 2018
Patent Number:
Title:
Hemostatic Compositions Containing Sterile Thrombin
Applicant:
Opposition Date:
Dec 22, 2017

Latest patents of Baxter International Inc. opposed by its competitors

Patent:
Grant Date:
Jun 19, 2019
Title:
Dialysis System Having Filtering Method For Determining Therapy Prescriptions
Oppositions:
1
Patent:
Grant Date:
Jan 2, 2019
Title:
Peritoneal Dialysis Optimized Using A Patient Hand-Held Scanning Device
Oppositions:
1
Patent:
Grant Date:
Nov 14, 2018
Title:
Rapidly Acting Dry Sealant And Methods For Use And Manufacture
Oppositions:
1
Patent:
Grant Date:
May 30, 2018
Title:
Dialysis System And Machine Having Therapy Prescription Recall
Oppositions:
1
Patent:
Grant Date:
Apr 4, 2018
Title:
Process For Making Dry And Stable Hemostatic Compositions
Oppositions:
2
Patent:
Grant Date:
Nov 22, 2017
Title:
Dialysis System Having Inventory Management Including Online Dextrose Mixing
Oppositions:
1
Patent:
Grant Date:
Sep 20, 2017
Title:
Recombinant Co-Expression Of Vitamin K Epoxide Reductase Subunit 1 To Improve Vitamin K Dependant Protein Expression
Oppositions:
1
Patent:
Grant Date:
Jun 28, 2017
Title:
Peritoneal Dialysis Optimized Using A Patient Hand-Held Scanning Device
Oppositions:
1
Patent:
Grant Date:
Apr 19, 2017
Title:
Oligopeptide-Free Cell Culture Media
Oppositions:
6

Competitors of Baxter International Inc.

ETHICON, INC

ETHICON, INC.

ETHICON INC.

Want to track Baxter International Inc.?

Feel free to send us a message here and we will get back to you